Point of Care Infectious Disease Testing Market

Report Description
Table of Contents

Report Description

The global point of care infectious disease testing market size is estimated to be USD xx billion in 2021 and is expected to witness a CAGR of xx% during the forecast period. Developments in the point of care diagnostics (POC) equipment is a key driver for the growth of the global point of care infectious disease testing market. Additionally, changing healthcare reform to being patient- centred care and increase in demand for decentralized infectious disease testing are some of the other drivers propelling the market growth. Nevertheless, challenges related to the development of highly sensitive & accurate POC testing and high cost of point of care infectious disease testing treatment are expected to restrain the global market growth.

Global Point of Care Infectious Disease Testing Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Disease Type

Based on disease type, the market is segmented into respiratory syncytial virus (RSV) POC, clostridium difficile POC, influenza/Flu POC, HPV POC, HBV POC, MRSA POC, HIV POC, pneumonia or streptococcus associated infections, HCV POC, HSV POC, TB & drug-resistant TB POC, and other POC. In 2021, the HIV POC segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the leading market players are investing in technologically advanced and accurate diagnosis devices are expected to improve penetration of these devices worldwide. Influenza/Flu POC segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the major pharmaceutical and biotechnology companies investing in the point of care infectious disease testing market.

By End User

Based on end user, the market is segmented into home, clinics, hospitals, assisted living healthcare facilities, laboratories, and others. In 2021, the clinics segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the increasing adoption of these platforms and devices in clinics worldwide. Assisted living healthcare facilities segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing application of testing devices in this sector as a consequence of rise in demand by the geriatric population globally.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in the share of healthcare expenditure in the per capita income, presence of key players in the region, growth in initiatives from government, accessibility of technological advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the intensely increase in burden of chronic infectious, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, are the major factors in this region.

Competitor Insights

Some of the key players in the point of care infectious disease testing market are Abbott Laboratories (U.S.); Bio-Rad Laboratories, Inc. (U.S.); Quest Diagnostics, Inc. (U.S.); Thermo Fisher Scientific, Inc. (U.S.); F.Hoffmann-La Roche Ltd (Switzerland); Danaher Corporation (U.S.); Siemens Healthineers AG (Germany); Sight Diagnostics Ltd (Israel); bioMérieux SA (France); Cardinal Health, Inc. (U.S.); Trinity Biotech (Ireland) Becton Dickinson Company (U.S.); and Becton Dickinson Company (U.S.). The leading players operating in the point of care infectious disease testing industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The point of care infectious disease testing market report is categorized into the following segments and subsegments: